KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) EBT Margin (2016 - 2025)

Eli Lilly's EBT Margin history spans 17 years, with the latest figure at 42.85% for Q4 2025.

  • For Q4 2025, EBT Margin rose 562.0% year-over-year to 42.85%; the TTM value through Dec 2025 reached 39.48%, up 1133.0%, while the annual FY2025 figure was 39.48%, 1133.0% up from the prior year.
  • EBT Margin reached 42.85% in Q4 2025 per LLY's latest filing, up from 41.09% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 43.56% in Q2 2025 to a low of 4.5% in Q3 2023.
  • Average EBT Margin over 5 years is 26.27%, with a median of 25.71% recorded in 2022.
  • Peak YoY movement for EBT Margin: crashed -1805bps in 2023, then soared 2721bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 23.0% in 2021, then increased by 25bps to 28.71% in 2022, then dropped by -7bps to 26.82% in 2023, then surged by 39bps to 37.23% in 2024, then grew by 15bps to 42.85% in 2025.
  • Per Business Quant, the three most recent readings for LLY's EBT Margin are 42.85% (Q4 2025), 41.09% (Q3 2025), and 43.56% (Q2 2025).